Analysis | Metabolite Name | Measured Value | Units | Exercise | Group | Sex | Type |
---|---|---|---|---|---|---|---|
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 470229 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 687676 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 928845 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 932183 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 933685 | Peak area normalized | Yes | PAH | Male | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 943931 | Peak area normalized | No | Borderline Pressures | Male | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 975491 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1042376 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1057597 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1064661 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1069200 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1096855 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1139710 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1149660 | Peak area normalized | No | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1169682 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1176251 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1179389 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1179898 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1181391 | Peak area normalized | No | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1213064 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1226424 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1232206 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1232927 | Peak area normalized | No | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1235794 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1236726 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1258866 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1258886 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1259744 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1262199 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1265593 | Peak area normalized | Yes | Healthy | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1269261 | Peak area normalized | No | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1273892 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1281496 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1282476 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1284693 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1294196 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1295046 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1301981 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1302558 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1308480 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1310809 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1328926 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1334495 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1345321 | Peak area normalized | No | Healthy | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1347805 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1347893 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1369648 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1370661 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1400145 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1401982 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1408262 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1409620 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1414179 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1435761 | Peak area normalized | Yes | Healthy | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1439932 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1440667 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1440726 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1448791 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1465034 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1471137 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1473872 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1482210 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1482919 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1484085 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1487320 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1487523 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1500598 | Peak area normalized | Yes | Borderline Pressures | Male | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1508522 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1513181 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1517430 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1528535 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1530198 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1531770 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1537106 | Peak area normalized | No | Normal Pressures | Male | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1538101 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1539477 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1541285 | Peak area normalized | Yes | Normal Pressures | Male | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1546152 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1565057 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1566299 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1569563 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1569585 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1569755 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1575047 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1575386 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1576735 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1582087 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1590006 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1590348 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1596173 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1599008 | Peak area normalized | No | PAH | Male | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1600645 | Peak area normalized | No | Healthy | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1601174 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1602720 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1611786 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1618663 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1618722 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1621768 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1628189 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1628189 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1628189 | Peak area normalized | Yes | Healthy | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1629608 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1630156 | Peak area normalized | No | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1634385 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1634610 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1635390 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1637293 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1638274 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1639798 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1644288 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1648684 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1651960 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1655495 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1658407 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1662427 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1666429 | Peak area normalized | No | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1670548 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1675907 | Peak area normalized | Yes | Healthy | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1678428 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1688044 | Peak area normalized | No | Healthy | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1689452 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1689607 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1691165 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1695990 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1696457 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1701589 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1702361 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1714495 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1732620 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1738129 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1739262 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1743178 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1748884 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1750041 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1754108 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1754794 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1757517 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1760521 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1779340 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1779933 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1786983 | Peak area normalized | No | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1791426 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1791939 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1798136 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1801382 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1801566 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1803653 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1817205 | Peak area normalized | No | Healthy | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1822973 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1823517 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1831338 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1834669 | Peak area normalized | Yes | PAH | Male | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1838039 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1844061 | Peak area normalized | No | Borderline Pressures | Male | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1846511 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1854231 | Peak area normalized | No | Borderline Pressures | Male | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1856484 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1863219 | Peak area normalized | No | LowRisk | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1865927 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1875096 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1878092 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1882588 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1885476 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1891082 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1891649 | Peak area normalized | Yes | LowRisk | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1892602 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1893488 | Peak area normalized | Yes | Borderline Pressures | Male | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1898955 | Peak area normalized | No | LowRisk | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1908196 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1920195 | Peak area normalized | Yes | Borderline Pressures | Male | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1925874 | Peak area normalized | No | PAH | Male | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1930734 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1942287 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1942430 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1952714 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1954930 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1956133 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1958744 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1964784 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1977487 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1985903 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 1991560 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 2011345 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 2018355 | Peak area normalized | Yes | LowRisk | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 2019782 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 2024357 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 2031268 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 2043372 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 2044432 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 2053864 | Peak area normalized | Yes | PAH | Male | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 2066426 | Peak area normalized | No | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 2069624 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 2088800 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 2101061 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 2104144 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 2106960 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 2124855 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 2127784 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 2148716 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | PHENYLALANINE (M-H)- | 2158897 | Peak area normalized | No | Healthy | Female | Non-invasive |
Return to search page